Info
The information provided is not a substitute for any advice given to you by your medical team or information within the patient information leaflet in your medicine pack. If you have any questions after reading this information, talk to your medical team — they’re here to help you.

Supporting You on Your Treatment

Information about Interstitial Lung Disease

Living Well with Pulmonary Fibrosis

NP-GB-106529 | March 2026

 

If you live in the UK and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the yellow card scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of this medicine.

If you live in the Republic of Ireland and you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Health Products Regulatory Authority at www.hpra.ie or by email to medsafety@hpra.ie. By reporting side effects, you can help provide more information on the safety of this medicine.

This website has been developed by Boehringer Ingelheim and is intended for people with progressive pulmonary fibrosis who have been prescribed OFEV® (nintedanib).

This website is intended for people with progressive pulmonary fibrosis who have been prescribed treatment with OFEV® (nintedanib). OFEV® is used to treat idiopathic pulmonary fibrosis, or other chronic fibrosing interstitial lung diseases that are showing signs of progression and these diseases are referred to on this website collectively as ‘progressive pulmonary fibrosis’.

This website aims to provide you with information about your disease and how to manage your symptoms or the side effects of your treatment, as well as to give you details on holistic support available.

The information on this website has been developed to enhance, but not replace, the advice and help of your medical team. If you have any questions after reading this website, or any further concerns, always talk to your medical team – i.e., a nurse, doctor or pharmacist – they are here to help you.

You’ll also find more information about OFEV® in your Patient Information Leaflet (PIL), included with your OFEV® medication pack, or on www.medicines.org.uk/emc/product/7705/pil if you live in the United Kingdom, or on www.medicines.ie/medicines/ofev-150-mg-soft-capsules-33198/patient-info if you live in the Republic of Ireland.

Vault id: NP-GB-106529